Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by jojomarch

V.TLT

RE:RE:RE:RE:GBM trial soon

I just re-read it  . INDICATIONS ....plural  , good catch...

September 13, 2017

V.TLT

RE:RE:New Q3 Presentation

Great presentation !!! Alittle over my head but good thing Bencro and a few...

September 13, 2017

V.TLT

RE:RE:RE:RE:RE:RE:Other Researchers.

So mid to late october seems to be the crucial timing with the 6 months low...

September 13, 2017

V.TLT

RE:RE:Roche interest is not good news...

Gojo i respect your noble opinion but i have to put my trust in RW and that...

September 13, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:The future look very promising...

MACMAN you suffer from common sense ... i hope it's contagious and...

September 13, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:The future look very promising...

I totally agree , if the 180 days cystoscopic analysis for the first three...

September 13, 2017

V.TLT

RE:RE:RE:RE:SEC SCHEDULE 14D-9 filing on Gilead 12B$ Kite's takeover

I wonder how RW feels about a BO ? Does he prefer to stay master of his...

September 12, 2017

V.TLT

RE:RE:RE:SEC SCHEDULE 14D-9 filing on Gilead 12B$ Kite's takeover

Enrique we spotted the same thing . Cheers

September 12, 2017

V.TLT

RE:SEC SCHEDULE 14D-9 filing on Gilead 12B$ Kite's takeover

Kite released data that 36% had a complete response to the treatment  ...

September 12, 2017

V.TLT

WOW

this bullboard is amazing . The quality of the posts  , from so many...

September 12, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Long-Lasting Antitumor Memory ...

I'm convinced TLT will do a JV and/or a licensing deal that will...

September 12, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:Long-Lasting Antitumor Memory ...

Like GUSTOES says ;  once the JV comes the maket will adjust instantly !...

September 11, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Long-Lasting Antitumor Memory ...

You are right PANDORA , the Venture  Exchange is the land of the...

September 11, 2017

V.TLT

RE:RE:RE:RE:RE:RE:Long-Lasting Antitumor Memory ...

LH , i agree , i did not buy this to make a 10% ROI . I bought my initial...

September 11, 2017

V.TLT

RE:RE:There seems to be a concerted effort to keep..

On July 25th TLT released the efficacy NR  ( 90 day recurrence free...

September 11, 2017

V.TLT

RE:RE:RE:EXAS...

I used to listen to the KEREPORT on TLT and once , after the 44 cents...

September 11, 2017

V.TLT

RE: 0.90 cent price target? Forget that.

If we go 9 for 9 there will be a line-up of big pharma executives on Queen...

September 11, 2017

V.TLT

RE:Pumpers out in full force

that's weird i thought bashers were out in full force . LOL !! Happy...

September 9, 2017

V.TLT

Bought

This TLT story is very exciting . I could not help myself , i bought more...

September 8, 2017

V.TLT

RE: NSCLC: New data from Bristol-Myers Squibb auto-immune Opdiv

Wow BENCRO with these sales figures for OPDIVO if TLT tackles NSCLC with a...

September 8, 2017

Prev ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 Next

Featured Company

AM Resources Corp.

AM Resources Corp. V.AMR

AM Resources Corporation is a Canada-based mining exploration company. The Company is a spodumene country play in Austria ... view more »